A world first: Discovery of a personalized therapy for cardiovascular disease
Researchers at the Montreal Heart Institute announced today results showing that patients with cardiovascular disease and the appropriate genetic background benefit greatly from the new medication dalcetrapib, with a reduction ...
Jan 12, 2015